Stocks · Health care · Pharmaceutical Preparations

Axsome Therapeutics, Inc.

AXSM Clue Score54
United States Fiscal year ends December CIK 0001579428 Results filed 2 Nov 2026

What the insiders did No buying or selling

By person

9 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Roger Jeffs
Director
—
—
—
58,367
$12.18M
−65.2%
Nick Pizzie
Chief Financial Officer
—
—
—
42,867
$8.94M
0.0%
Mark Coleman
Director
—
—
—
30,389
$6.34M
+108.1%
Mark E Saad
Director
—
—
—
11,431
$2.39M
+14.3%
Herriot Tabuteau
Chief Executive Officer
—
—
—
7,229
$1.51M
0.0%
Susan Mahony
Director
—
—
—
829
$172.97K
—
Mark L. Jacobson
Chief Operating Officer
—
—
—
0
$0.00
−100.0%
Ari Maizel
Chief Commercial Officer
—
—
—
0
$0.00
—
Hunter R. Murdock
General Counsel
—
—
—
0
$0.00
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.